India’s Drug Regulatory Reforms: Building Trust
Dilip Shah, the Secretary-General of the Indian Pharmaceutical Alliance advocates for a stronger and more…
Eli Lilly and Company India (Pvt) Ltd.
Last updated: 13.02.2014
Address: Eli Lilly and Company (India) pvt. Ltd., Plot# 92, Sector 32, Institutional Area, Gurgaon-122001, HARYANA, INDIA ,India
Tel: 91-124-4753000, 01
Web: https://www.lillyindia.co.in/
Company description
Eli Lilly and Company established its India operations in 1993 as a Joint venture with Ranbaxy Laboratories’ Limited. After the divestiture in 2001 it was Christened Eli Lilly and Company (India) Pvt. Ltd, and is today one of the most admired companies in terms of its focus on scientific selling, unique bouquet of products and services, working environment and focus on Ethics and Compliance Lilly India provides innovative answers to the needs of the people suffering from Diabetes, Cancer, Sepsis, Osteoporosis, Cardiovascular disorders and Growth hormone deficiency.
Major Achievements of Eli Lilly and Company (India) Pvt. Ltd.
In top 25 “Great Places to Work For in India” in 2003 and 2004 in a survey conducted by ‘Great Places to Work’ Institute
In top 25 in 2003 “Best Employers in India” in a survey conducted by Hewitt Associates.
2nd Best company to work for under ‘Biotech & Pharmaceutical’ category in 2008 in a survey conducted by Great Places to Work Institute USA’.
In top 10 “Best Companies to Work for in India’ in Business Today-Mercer-TNS survey 2008. Ranked 9th overall, achieving the unique distinction of being the only Pharmaceutical Company in this list.
Products and services
We strive to touch the lives of our customers by actively listening and responding to their needs with breakthrough products and medical expertise that is critical to their understanding and treatment of diseases.
Related
10 Pharma Leaders to Know in India
Indian pharma companies provide affordable generic drugs to patients in almost all countries across the globe,…
Africa: The Launchpad for Indian Pharma
Although most industry observers expect that Indian pharma exports to the US will pick up again in the coming…
Meeting US FDA Standards Across the Board in India
In a context where even well-established, multi-billion-dollar domestic companies have received warning letters…
Quality Compliance in Indian Pharma: The Learning Curve
One issue grinding the gears of the Indian pharmaceutical industry over recent years has been quality compliance.…
Bhupendra Sangani – CEO, Galentic, India
Bhupendra Sangani, founder and managing director of Galentic, one of India’s expert manufacturers of sterile and…
Satyanarayana Chava – CEO, Laurus Labs, India
Dr. Satyanarayana Chava, founder and CEO of Laurus Labs, provides insights into the distinctive model that has…
Luca Visini – Managing Director, Eli Lilly, India
Luca Visini, the recently appointed managing director of Eli Lilly & Company for India, shares with us his…
Letitia Robinson, Director, US FDA, India Office
Dr. Letitia Robinson, Director of the US FDA India Office, provides insights into the main goals and…
Interview: Deepak Birewar – Chairman & Founder, Inventys Research,…
Dr. Deepak Birewar, founder and chairman of the dynamically growing CDMO Inventys Research, highlights the crucial…
Interview: VS Reddy – Founder and Managing Director, British Biologicals,…
VS Reddy, fondly known as ‘The Protein Man of India’ and founder and managing director of British Biologicals,…
Interview: Jonathan Hunt – CEO, Syngene International, India
Jonathan Hunt, CEO of Syngene International, one of the fastest-growing and leading contract research and…
